Shinozaki, S.; Tahara, T.; Miura, K.; Lefor, A.K.; Yamamoto, H.
Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. Life 2023, 13, 1327.
https://doi.org/10.3390/life13061327
AMA Style
Shinozaki S, Tahara T, Miura K, Lefor AK, Yamamoto H.
Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. Life. 2023; 13(6):1327.
https://doi.org/10.3390/life13061327
Chicago/Turabian Style
Shinozaki, Satoshi, Toshiyuki Tahara, Kouichi Miura, Alan Kawarai Lefor, and Hironori Yamamoto.
2023. "Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study" Life 13, no. 6: 1327.
https://doi.org/10.3390/life13061327
APA Style
Shinozaki, S., Tahara, T., Miura, K., Lefor, A. K., & Yamamoto, H.
(2023). Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. Life, 13(6), 1327.
https://doi.org/10.3390/life13061327